[HTML][HTML] Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP …

…, C Dunn, P Dyer, A Elliott, A Evans, L Finch… - The Lancet …, 2021 - thelancet.com
Background Microbiological characterisation of co-infections and secondary infections in
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …

Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study

…, C Dunn, P Dyer, A Elliott, A Evans, L Finch… - The Lancet …, 2021 - thelancet.com
Background Prognostic models to predict the risk of clinical deterioration in acute COVID-19
cases are urgently required to inform clinical management decisions. Methods We …

[HTML][HTML] Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective …

…, C Dunn, P Dyer, A Elliott, A Evans, L Finch… - The Lancet, 2021 - thelancet.com
Background COVID-19 is a multisystem disease and patients who survive might have in-hospital
complications. These complications are likely to have important short-term and long-…

Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using …

…, C Dunn, P Dyer, A Elliott, A Evans, L Finch… - The Lancet …, 2021 - thelancet.com
Background Studies of patients admitted to hospital with COVID-19 have found varying
mortality outcomes associated with underlying respiratory conditions and inhaled corticosteroid …

Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study

…, C Dunn, P Dyer, A Elliott, A Evans, L Finch… - The Lancet …, 2021 - thelancet.com
Background Early in the pandemic it was suggested that pre-existing use of non-steroidal
anti-inflammatory drugs (NSAIDs) could lead to increased disease severity in patients with …

Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol …

…, C Dunn, P Dyer, A Elliott, A Evans, L Finch… - The Lancet …, 2021 - thelancet.com
Background Mortality rates in hospitalised patients with COVID-19 in the UK appeared to
decline during the first wave of the pandemic. We aimed to quantify potential drivers of this …

Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

…, C Dunn, P Dyer, A Elliott, A Evans, L Finch… - The Lancet Digital …, 2022 - thelancet.com
Background Dexamethasone was the first intervention proven to reduce mortality in patients
with COVID-19 being treated in hospital. We aimed to evaluate the adoption of …

A prospective diagnostic evaluation of accuracy of self-taken and healthcare worker-taken swabs for rapid COVID-19 testing

HR Savage, L Finch, R Body, RL Watkins… - PloS one, 2022 - journals.plos.org
Background Rapid diagnostic tests (RDTs) developed for point of care detection of SARS-CoV-2
antigen are recommended by WHO to use trained health care workers to collect …

Spore germination and recurrence of clostridioides difficile infection

L Finch - 2020 - eprints.nottingham.ac.uk
Clostridioides difficile-associated diarrhoea (CDAD) has emerged as a leading healthcare-associated
infection of great clinical and economic significance. The infection is not only …

Implementation study of SARS-CoV-2 antigen lateral flow tests in men's professional (Premiership) rugby union sports squads in England during the COVID-19 …

LS Finch, A Harris, C Lester, D Veal, K Jones, J Fulton… - Journal of Infection, 2022 - Elsevier
This study evaluated the validity and utility of antigen-detection rapid diagnostic tests (Ag-RDTs)
for SARS-CoV-2 in elite sports. The data on utility, ease of use and application for Ag-…